zg 63 has been researched along with ry 024 in 2 studies
| Studies (zg 63) | Trials (zg 63) | Recent Studies (post-2010) (zg 63) | Studies (ry 024) | Trials (ry 024) | Recent Studies (post-2010) (ry 024) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 8 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, DW; Cook, JM; Gan, T; He, X; Huang, Q; Liu, R; McKernan, R; Zhang, P | 1 |
| Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
2 other study(ies) available for zg 63 and ry 024
| Article | Year |
|---|---|
Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via compar
Topics: Animals; Benzodiazepines; Cell Line; Crystallography, X-Ray; Humans; Ligands; Mice; Models, Molecular; Radioligand Assay; Receptors, GABA-A; Recombinant Proteins; Regression Analysis; Structure-Activity Relationship | 1998 |
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |